RNA regulator of melanoma: New target for cancer therapy

A new study released by Genome Research has identified a RNA regulator that could result in new therapy for melanoma. Lead researchers Drs. Ross Flockhart and Paul Khavari from Stanford University have demonstrated the ability of RNA to be sequenced in a manner that more easily identifies melanoma progression. The researcher's believe that this method will lead to "a better understanding of how tumors evade drugs, and how previously unknown players...could be new targets for treatment." To learn more about this study, click here..